Gilead upped on HIV franchise; Merck downgraded on Keytruda LoE at Deutsche Bank
Gilead (GILD) stock won an upgrade from Deutsche Bank on HIV treatment boost, while Merck (MRK) stock received a downgrade on ...
Designing antivirals for shape-shifting viruses
Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments ...
News Medical1d
Breakthrough computational tool enhances design of targeted antiviral therapies
Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments ...
Flu cases up due to lagging vaccinations and better tests
Cases remain high, according to data from the Georgia Department of Health and the Centers for Disease Control and Prevention. But metro Atlanta doctors say it's not too late to get vaccinated against ...
Opinion: Long COVID is solvable, but we need more clinical trials
Some people may remain ill after COVID infection because the virus still lurks in their bodies. The looming question now is: ...
verywellhealth3d
Flu Season Is Really Bad This Year. Here Are 3 Ways To Protect Yourself
Flu season is in full force in the United States. At least 310,000 flu-related hospitalizations and 13,000 deaths have been ...
pulmonologyadvisor6d
COVID Antiviral, mAb Treatments Reduce Mortality and Hospitalization Rates
Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.